Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

Nature

Volumn 411, Issue 6841, 2001, Pages 1058-1064

  Ochsenbein, Adrian F ^a,b   Sierro, Sophie ^a   Odermatt, Bernhard ^a   Pericin, Marcus ^a   Karrer, Urs ^a   Hermans, Jan ^c   Hemmi, Silvio ^d   Hengartner, Hans ^a   Zinkernagel, Rolf M ^a  

^a INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; CELLS; IMMUNOLOGY; MUTAGENESIS;

VERTEBRATE IMMUNE SYSTEM;

TUMORS;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HOST CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; LYMPHOID ORGAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; SOLID TUMOR; TUMOR CELL; TUMOR LOCALIZATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, NEOPLASM; ANTIGENS, VIRAL; GLYCOPROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOLOGIC SURVEILLANCE; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; LYMPHOID TISSUE; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; NEOPLASMS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR ESCAPE;

ANIMALIA; VERTEBRATA;

EID: 0035963379     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35082583     Document Type: Article

References (30)

1. Tumour immunology: The first century
2. Tumour antigens recogniced by T lymphocytes
3. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II or III breast cancer
4. Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy
5. + T cells by B7-transfected melanoma cells
6. Costimulation of antitumour immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
7. Can co-stimulated tumour immunity be therapeutically efficacious?
8. Tolerance, danger, and the extended family
9. Fibroblasts as efficient antigen-presenting cells in lymphoid organs
10. Immune surveillance against a peripheral solid tumour fails because of immunological ignorance
11. Role of cell mediated immunity in bacterial infections
12. Cross-presentation: A general mechanism for CTL immunity and tolerance
13. Role of bone marrow-derived cells in presenting MHC class I-restricted tumour antigens
14. + T cell responses to infectious agents, tumours, transplants, and vaccines
15. OmpA targets dendrite cells, induces their maturation and delivers antigen into the MHC class I presentation pathway
16. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay
17. Protective antitumour immunity induced by immunization with completely allogenic tumour cells
18. CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes
19. Antigen expressed on tumour cells fails to elicit an immune response, even in the presence of increased numbers of tumour-specific cytotoxic T lymphocyte precursors
20. Tumour-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumour growth in vivo
21. Induction of antigen-specific T cell anergy: An early event in the course of tumour progression
22. Escape of thymocytes and mature T cells from clonal deletion due to limiting tolerogen expression levels
23. Virus-specific MHC class II-restricted TCR-transgenic mice: Effects on humoral and cellular immune response after viral infection
24. Differential T cell costimulatory requirements in CD28-deficient mice
25. On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleenless (Hox11-/-) mutant mice
26. T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumour rejection: An important tole of B7/BB1 in the induction, recruitment, and effector function of antitumour T cells
27. Maturation of cytotoxic T lymphocytes against a B7-transfected nonmetastatic tumour: A critical role for costimulation by B7 on both tumour and host antigen-presenting cells
28. Specific T helper requirement for optimal induction of cytotoxic T lymphocytes against major histocomatibility complex class II negative tumours
29. Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness
30. A reassessment of the role of B7-1 expression in tumour rejection